Tritanium 3D-Printed Implants

About Stryker

Stryker Corporation's mission is to make healthcare better by providing innovative products and services that improve patient and hospital outcomes. The company has achieved this through strategic diversification across high-growth medical device segments, including its flagship Mako robotic-assisted surgery platform, and consistent execution of a disciplined acquisition strategy to bolster its technology portfolio. Its core strategy revolves around deep clinical integration, global market penetration, and sustained R&D investment to drive procedural efficiency and value-based care. With a market capitalization exceeding $126 billion, Stryker is a financially robust leader poised to capitalize on aging demographics and technological adoption in surgery.

Therapeutic Areas